scispace - formally typeset
T

Thomas M. Barber

Researcher at University of Warwick

Publications -  131
Citations -  4496

Thomas M. Barber is an academic researcher from University of Warwick. The author has contributed to research in topics: Polycystic ovary & Medicine. The author has an hindex of 27, co-authored 111 publications receiving 3250 citations. Previous affiliations of Thomas M. Barber include Imperial College London & Coventry Health Care.

Papers
More filters
Journal ArticleDOI

Obesity and polycystic ovary syndrome

TL;DR: The various mechanisms that might underlie the link between excess adiposity and PCOS are considered – including the effects of differential insulin sensitivity, abnormal steroid hormone metabolism and adipocytokine secretion.
Journal ArticleDOI

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

M. Geoffrey Hayes, +55 more
TL;DR: Common genetic susceptibility loci in European ancestry women for the National Institutes of Health PCOS phenotype are identified, which confers the highest risk for metabolic morbidities, as well as reproductive hormone levels, and implicate neuroendocrine changes in disease pathogenesis.
Journal ArticleDOI

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.

TL;DR: This work characterized the metabolic and endocrine profiles of PCOS women who are oligomenorrhoeic but normoandrogenaemic, and compared these to otherPCOS women and controls.
Journal ArticleDOI

The health benefits of dietary fibre

TL;DR: Given the plethora of scientific evidence that corroborate the multiple and varied health benefits of dietary fibre, and the risks associated with a diet that lacks fibre, the optimization of fibre within the authors' diets represents an important public health strategy to improve both metabolic and overall health.
Journal ArticleDOI

PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity

TL;DR: An apparently divergent effect of PTEN mutations is demonstrated: increased risks of obesity and cancer but a decreased risk of type 2 diabetes owing to enhanced insulin sensitivity.